These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 3589620

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP.
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [Abstract] [Full Text] [Related]

  • 23. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents.
    Gabbuti A, Romanò L, Blanc P, Meacci F, Amendola A, Mele A, Mazzotta F, Zanetti AR.
    Vaccine; 2007 Apr 20; 25(16):3129-32. PubMed ID: 17291637
    [Abstract] [Full Text] [Related]

  • 24. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination.
    Williams IT, Goldstein ST, Tufa J, Tauillii S, Margolis HS, Mahoney FJ.
    Pediatr Infect Dis J; 2003 Feb 20; 22(2):157-63. PubMed ID: 12586980
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Immune response to plasma-derived hepatitis B vaccine in hospital health personnel of Parma].
    Magnani G, Bertoletti A, Calzetti C, Campari M, Pizzaferri P, Schianchi C, Vitali P.
    Acta Biomed Ateneo Parmense; 1989 Feb 20; 60(1-2):73-9. PubMed ID: 2535096
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Screening and vaccination against hepatitis B among health personnel. Short-term results].
    Bertoglio C, Ariotti G, Demicheli V, Marino G, Piccinelli V, Leccardi E, Allosia GP, Corti E, Ballerini P.
    Minerva Med; 1987 Apr 30; 78(8):537-42. PubMed ID: 2952903
    [Abstract] [Full Text] [Related]

  • 33. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
    Gałaj A, Grześk G, Borys D, Durmowicz A, Grześk E, Szadujkis-Szadurski L.
    Wiad Lek; 2004 Apr 30; 57(5-6):217-20. PubMed ID: 15518064
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients.
    Sorkhi H, Dooki MR, Ebrahimnejad MS.
    J Med Assoc Thai; 2006 Oct 30; 89(10):1648-53. PubMed ID: 17128839
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Observation on effects of hepatitis B vaccine immunization for 12 years in children in Beijing].
    Gong XH, Wang FZ, Li H, Liu LR, Li YH, Wang BL, Li LQ, Zhang Z, Han QY, Tang YW.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Jul 30; 39(4):265-8. PubMed ID: 16194384
    [Abstract] [Full Text] [Related]

  • 40. [Thymopentin as adjuvant therapy in the hepatitis B vaccination of non- or hyporesponsive subjects].
    Fuliano P, Fontana L, Bigolari M, Bovone U, Orengo G, Astengo F.
    Minerva Med; 1990 May 30; 81(5):407-13. PubMed ID: 2198499
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.